GlycoMimetics (NASDAQ:GLYC – Get Rating) posted its quarterly earnings results on Wednesday. The biotechnology company reported ($0.17) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.17), reports. GlycoMimetics Price Performance GlycoMimetics stock opened at $1.53 on Friday. GlycoMimetics has a one year low of $0.51 and a one year high of $4.16. […]
GlycoMimetics (NASDAQ:GLYC – Get Rating) will post its quarterly earnings results before the market opens on Wednesday, May 3rd. Analysts expect GlycoMimetics to post earnings of ($0.17) per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link. GlycoMimetics Price Performance Shares of GlycoMimetics […]
GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $1.88 and traded as low as $1.25. GlycoMimetics shares last traded at $1.33, with a volume of 96,727 shares changing hands. Wall Street Analysts Forecast Growth A number of research […]
GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) – Equities researchers at Jefferies Financial Group issued their Q1 2023 earnings per share estimates for GlycoMimetics in a note issued to investors on Wednesday, March 29th. Jefferies Financial Group analyst R. Song anticipates that the biotechnology company will earn ($0.17) per share for the quarter. The consensus estimate […]
GlycoMimetics (NASDAQ:GLYC – Get Rating)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $8.00 target price on the biotechnology company’s stock. Separately, StockNews.com lowered GlycoMimetics from a “hold” rating to a “sell” rating in a report on […]